Sort
82,697 grants matching “vaccine development”
Surgery Branch Cell Prep Core
$1,122,261John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Cell Production Core Facility
$1,122,261John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
$1,122,164John H Eldridge · Profectus Biosciences, Inc. · R01 · FY2013 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,122,097Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Development of a Universal Influenza Vaccine
$1,121,460Frank R. Jones · Etubics Corporation · R01 · FY2015 · AI
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,121,375Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Vaccines to counter emerging antibiotic resistance
$1,121,364Wendy L Picking · University Of Kansas Lawrence · R01 · FY2020 · AI
Vaccines to counter emerging antibiotic resistance
$1,121,304Wendy L Picking · University Of Kansas Lawrence · R01 · FY2021 · AI
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$1,121,263Mark M Davis · Stanford University · U19 · FY2019 · AI
Vaccine Discovery for Chagas Disease
$1,121,187Rick L Tarleton · University Of Georgia · P01 · FY2007 · AI
Structure-Based Vaccine Design for Hepatits C Virus
$1,120,994Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2021 · AI
Alabama-Clinical Trials Unit
$1,120,888Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2010 · AI
University of California, San Diego Clinical Trial Unit
$1,120,724Stephen A Spector · University Of California, San Diego · U01 · FY2009 · AI
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
$1,120,233Kathryn M Anastos · Albert Einstein College Of Medicine · U54 · FY2023 · CA
Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models
$1,120,190Ashley Brown · University Of Florida · R01 · FY2016 · AI
rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses
$1,120,171John H Eldridge · Profectus Biosciences, Inc. · R01 · FY2012 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2019 · AI
MRI: Acquisition of a Cryo Field Emission Transmission Electron Microscope
$1,120,000Susan E Anagnost · Suny College Of Environmental Science And Forestry · · FY2015 · BIO
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2020 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2023 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2021 · AI
A Synthetic Platform for Non-Antibiotic Eradication of Bacterial Infections
$1,120,000Christophe Herman · Baylor College Of Medicine · DP1 · FY2022 · AI
Environmental Causes of Type 1 Diabetes
$1,119,581Marian J. Rewers · University Of Colorado Denver · U01 · FY2006 · DK
DNA AND PROTEIN IMMUNOGENS FOR SIV/HIV VACCINES
$1,119,409Emory University · P01 · FY2003 · AI
RNA Structural Motif Analysis Revisited: Towards a Systematic Understanding of Noncoding RNA as Modular Biomolecules
$1,119,355Shaojie Zhang · University Of Central Florida · R01 · FY2025 · GM